Theory and Knowledge for Researching the Target POI
Acute Myeloid Leukemia (AML) is one of the most typical forms of cancer in adults, according to a recent study provided by the Centers for Disease Control and Prevention (Tsai et al., 2014). To gain a deeper insight into the problem, one should consider viewing it from different perspectives. Several courses on the subject matter, including the current one, have helped me understand the needs of the patients that have to deal with AML and the associated issues.
Among the previous courses that shaped my understanding of what AML was and how AML patients’ needs had to be tended to, one must bring up the ones that provided general information on designing a nursing care plans. Also, specific ones that detailed the types of leukemia, the treatment and management tools and strategies that could be used to handle the issue, etc., deserve to be mentioned. Eventually, one must consider the experience that I have had so far, and that included dealing with some of the leukemia-related issues. To be more specific, I assisted in preventing the risk of infection among AML patients. The experience gained in the process helped me understand the essential characteristics and specific needs of POI better.
Justification of the Choice of the POI
As stressed above, AML is ranked among the most common diseases that cause death in adults (Wang, Jabbour, & Douer, 2015). Therefore, making sure that the appropriate preventive measures, treatment strategies, and supervision of the therapy outcomes should be designed is crucial to the patient outcomes. Studying the factors that affect the target population in different settings will serve as the foil for the design of an efficient nursing strategy that will help improve the current service quality. As a result, the patients will be exposed to the threat of developing the AML to a lesser degree.
The PI affects the staff and the clients directly. While the former is bound to acquire the skills that will help manage the AML audience’s needs in a more careful manner, the latter will learn more about the threat and, therefore, will develop the habits that will allow avoiding the danger of AML successfully. The identified changes are crucial since the current state of the identified POI in healthcare can be defined as critical, with the AML rates increasing every year (Grosicki, Barchnicka, Bodzenta, Haus, & Jaśkowiec, 2013). Moreover, the improved strategy is bound to have a positive global effect since the problem under analysis has spread across the world (Tsai et al., 2014).
Plan for Researching the POI
In order to address the issue, one will have to contact nurse administrators in the chosen facility to study the source of the problem closer. Furthermore, the latest studies that address the threat will have to be considered. Thus, one will be able to shed more light on the AML development problem. Finally, a survey must be conducted among patients to find out what causes a drop in awareness rates.
To embrace the array of factors that affect the situation, one will have to conduct interviews with the nurse administrators, as well as the local staff, learning more about the patterns of information management and the provision of care. The tools that nurses use to build awareness will have to be identified and analyzed carefully. Furthermore, a survey must be administered to the patients so that an objective assessment of the effects that the current nursing approaches have on the POI could be determined. Finally, the latest studies addressing the issue of AML will have to be considered.
References
Grosicki, S., Barchnicka, A., Bodzenta, E., Haus, O., & Jaśkowiec, A. (2013). Secondary acute myeloid leukemia (sAML) immediately after intensive chemotherapy of acute lymphoblastic leukemia (ALL). Journal of Leukemia, 1(1), 2-4.
Tsai1, R. J., Luckhaupt, S. E., Schumacher, P., Cress, R. D., Deapen, D. M., & Calvert, G. M. (2014). Acute myeloid leukemia risk by industry and occupation. Leukemia & Lymphoma, 55(11), 2584–2591.
Wang, E. S., Jabbour, E. J., & Douer, D. (2015). Novel management options for adult patients with progressive acute lymphoblastic leukemia: Introduction. Clinical Advances in Hematology & Oncology, 13(6), 8-11.